<DOC>
	<DOCNO>NCT01179971</DOCNO>
	<brief_summary>Purpose : To investigate differential effect polyunsaturated fatty acid compare standard control therapy ( olive oil ) disease activity biochemical parameter patient rheumatoid arthritis ( RA ) , resp . psoriasis arthritis ( PA ) .</brief_summary>
	<brief_title>n-3 n-6 Fatty Acids Rheumatoid Arthritis</brief_title>
	<detailed_description>Methods : Double-blinded , four-armed randomise control trial 3.0 g/d either n-3 long chain polyunsaturated fatty acid ( LC-PUFA ) gamma linolenic acid ( GLA ) , resp . combination 1.5 g/d , resp . 3.0 g/d olive oil 12 week . Outcome parameter disease activity score ( DAS28 ) , C-reactive protein , concentration n-3 LC-PUFA , resp . GLA plasma lipid ( PL ) , cholesterol ester ( CE ) , erythrocyte membrane ( EM ) , serum concentration arachidonic acid ( AA ) . Conventional antirheumatic immunosuppressive therapy could change within defined limit .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Efamol</mesh_term>
	<criteria>Rheumatoid Psoriasis arthritis Severe diseases heart , liver , lung airway Noncompliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>n-3 fatty acid</keyword>
	<keyword>n-6 fatty acid</keyword>
	<keyword>anti-inflammatory action</keyword>
	<keyword>clinical trial</keyword>
	<keyword>randomize double-blinded</keyword>
	<keyword>incorporation fatty acid</keyword>
</DOC>